Has Gretchen Helvey received payments from drug or device companies?

Yes. Drug and device makers reported $8,277 in general payments to Gretchen Helvey across 256 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gretchen Helvey did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gretchen Helvey come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gretchen Helvey

Nurse Practitioner · Post Falls, IDNPI 1790485266

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.5% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,277in general payments, 2019–2025

Across 256 payments — averaging $32.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$818
Novartis$795
Johnson & Johnson$743
AstraZeneca$730
Exelixis Inc.$608
Daiichi Sankyo Inc.$601
plus $4K from 38 others

What the payments were for

Food & beverage$7,98796%
Education$2904%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	23	$818
Novartis	55	$795
Johnson & Johnson	19	$743
AstraZeneca	12	$730
Exelixis Inc.	16	$608
Daiichi Sankyo Inc.	6	$601
Gilead	7	$481
Pfizer	14	$369
Bristol Myers Squibb	21	$318
Seagen Inc.	5	$287
Merck	7	$244
Eisai Inc.	10	$208
AbbVie	7	$197
Bayer	3	$142
Amgen	1	$135
Sanofi	7	$133
Syndax Pharmaceuticals, Inc.	1	$127
Takeda Pharmaceuticals U.S.A., Inc.	1	$125
Incyte Corporation	1	$123
Agios Pharmaceuticals, Inc.	1	$123
Karyopharm Therapeutics Inc.	1	$117
Genentech USA, Inc.	4	$91
Lilly USA, LLC	4	$90
Adaptive Biotechnologies Corporation	3	$62
Array Biopharma Inc	3	$61
Genmab U.S., Inc.	2	$54
Immunocore Limited	1	$49
Boehringer Ingelheim	2	$47
Astellas Pharma US Inc	2	$45
Acrotech Biopharma Inc.	2	$40
Accord Healthcare, Inc.	2	$40
Pharmacyclics LLC, An Abbvie Company	1	$34
Menarini Silicon Biosystems, Inc.	1	$26
Progenics Pharmaceuticals, Inc.	1	$24
Sumitomo Pharma America, Inc.	1	$23
Spectrum Pharmaceuticals Inc.	1	$22
Delcath Systems	1	$22
Servier Pharmaceuticals LLC	1	$21
Regeneron Healthcare Solutions, Inc.	1	$20
AVEO Pharmaceuticals, Inc.	1	$19
Beigene USA, Inc.	1	$18
Mirati Therapeutics, Inc.	1	$16
Secura Bio, Inc.	1	$15
Azurity Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,277 in reported general payments places this provider in the 95th percentile of 570 nurse practitioner providers in Idaho.

See all nurse practitioner providers in Idaho →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	46	$1,267
Ondansetron OdtOndansetron	24	$1,089
Famciclovir	11	$489
Prochlorperazine Maleate	17	$355
Hydrocortisone	19	$287
Dexamethasone	16	$238
Levothyroxine Sodium	27	$237
Letrozole	20	$170
Hydroxyzine Hcl	11	$169
Omeprazole	13	$158
Gabapentin	18	$137
Prednisone	33	$105
Acyclovir	26	$103
Potassium Chloride	12	$62
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	12	$38

Paid to pharmacies, not to this prescriber.